Canada markets closed

Cue Biopharma Inc (1UC.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
1.4200-0.0100 (-0.70%)
At close: 08:02AM CEST
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-49,971
-50,733
-53,010
-44,161
-44,785
-
Depreciation & amortization
3,405
3,436
1,806
-1,778
-3,145
-
Stock based compensation
8,128
8,180
9,496
11,516
10,481
-
Change in working capital
-715
-934
356
-4,387
5,435
-
Accounts receivable
-1,204
-1,641
3,085
-1,725
-662.584
-
Accounts Payable
1,768
770
83
520.398
741.265
-
Other working capital
-38,967
-39,961
-41,977
-39,750
-33,089
-
Other non-cash items
167
167
-137
-
-563.232
-4,278
Net cash provided by operating activites
-38,912
-39,961
-41,806
-38,837
-32,494
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-171
-913.039
-595.259
-46.353
Purchases of investments
-
0
-29,445
0
-9,949
-
Sales/Maturities of investments
10,000
25,000
5,000
10,000
15,000
-
Net cash used for investing activites
9,945
25,002
-24,610
9,109
4,456
-
Cash flows from financing activities
Debt repayment
-3,000
-2,000
0
-
-
-
Common stock issued
16,741
13,387
39,300
17,385
56,682
-
Other financing activites
-
-
-341
-750.128
-271.051
-91.027
Net cash used privided by (used for) financing activities
13,826
11,860
53,659
19,233
58,614
-
Net change in cash
-15,141
-3,099
-12,757
-10,495
30,576
-
Cash at beginning of period
56,321
51,764
64,521
75,016
44,440
-
Cash at end of period
41,180
48,665
51,764
64,521
75,016
-
Free Cash Flow
Operating Cash Flow
-38,912
-39,961
-41,806
-38,837
-32,494
-
Capital Expenditure
-
-
-171
-913.039
-595.259
-46.353
Free Cash Flow
-38,967
-39,961
-41,977
-39,750
-33,089
-